O'Neill P A, Morton P B, Stark R D
Br J Clin Pharmacol. 1985 Jun;19(6):793-7. doi: 10.1111/j.1365-2125.1985.tb02716.x.
Previous work has left unresolved questions on whether promethazine reduces the sensation of breathlessness. This study was designed to provide a definitive answer and to determine the contributions from promethazine's major pharmacological actions. Twelve healthy subjects participated in a double-blind, within-subject comparison of promethazine and placebo each given acutely by mouth. Breathlessness was assessed with visual analogue scales during a progressive exercise test and was related to minute ventilation. Promethazine had no significant effect on breathlessness nor on the relationship between breathlessness and ventilation. The role of histamine-antagonism was investigated in a subgroup of the subjects by administration of mebhydrolin. No effect on breathlessness was detected. In contrast, the standard phenothiazine, chlorpromazine, caused a marked and statistically significant reduction in breathlessness without affecting ventilation and without causing detectable sedation. This unexpected finding merits further study in patients and is discussed with reference to the role of chlorpromazine as a constituent of Brompton's Mixture.
以往的研究尚未解决异丙嗪是否能减轻呼吸困难感的问题。本研究旨在给出明确答案,并确定异丙嗪主要药理作用的贡献。12名健康受试者参与了一项双盲、受试者自身对照试验,分别口服给予异丙嗪和安慰剂。在递增运动试验期间,用视觉模拟量表评估呼吸困难情况,并将其与分钟通气量相关联。异丙嗪对呼吸困难以及呼吸困难与通气之间的关系均无显著影响。通过给予美比妥林,在部分受试者亚组中研究了组胺拮抗作用。未检测到对呼吸困难有影响。相比之下,标准吩噻嗪类药物氯丙嗪可显著且有统计学意义地减轻呼吸困难,且不影响通气,也未引起可检测到的镇静作用。这一意外发现值得在患者中进一步研究,并参考氯丙嗪作为布朗普顿合剂成分的作用进行了讨论。